Precision Oncology: Genomics Guided Care – Taxonomy and Framework
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
In 2009, Carl Ola Landgren noticed that nearly all of his multiple myeloma patients were responding to the state-of-the-art drugs he was giving them at…
Sotorasib was the first approved KRAS inhibitor granted marketing authorisation by the US Food and Drug administration (FDA) by use of the accelerated approval pathway…
Sequential CD7 CAR T-cell therapy plus haploidentical HSCT without GVHD prophylaxis is effective and safe in CD7-positive hematologic malignancies.
Dr James Shultz, (University of Miami Miller School of Medicine, Miami, USA), Dr Ana Patricia Ortiz (University of Puerto Rico, and University of Puerto Rico…
Hesham Abdullah, MD, MSc, of GSK, discusses myelofibrosis and the uses of momelotinib, also known as Ojjaara, to treat it.
Caribbean small island developing states are becoming increasingly vulnerable to compounding disasters, prominently featuring climate-related hazards and pandemic diseases, which exacerbate existing barriers to cancer…
Peruse the current issue of The Lancet Oncology, a monthly journal covering international issues relevant to clinical cancer specialists worldwide
Oncogene – The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia
The abstract submission system is now open
The PRECEDE study demonstrated the feasibility of a large-scale early detection and prevention program for pancreatic cancer.